Literature DB >> 30667461

Consumer Responses to Price Disclosure in Direct-to-Consumer Pharmaceutical Advertising.

Jace B Garrett1, William B Tayler2, Ge Bai3, Mariana P Socal4, Antonio J Trujillo4, Gerard F Anderson4.   

Abstract

Mesh：

Year:  2019        PMID： 30667461      PMCID： PMC6439697          DOI： 10.1001/jamainternmed.2018.5976

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  3 in total

1.  Naming Convention, Interchangeability, and Patient Interest in Biosimilars.

Authors:  Mariana P Socal; Jace B Garrett; William B Tayler; Ge Bai; Gerard F Anderson
Journal:  Diabetes Spectr       Date:  2020-08

2.  Association of Direct-to-Consumer Advertising of Prescription Drugs With Consumer Health-Related Intentions and Beliefs Among Individuals at Risk of Cardiovascular Disease.

Authors:  Matthew D Eisenberg; Yashaswini Singh; Neeraj Sood
Journal:  JAMA Health Forum       Date:  2022-08-05

3.  Does price disclosure in pharmaceutical advertising result in price transparency? Evidence from a randomized experiment.

Authors:  Ilene L Hollin; Jennifer Gerard Ball
Journal:  Explor Res Clin Soc Pharm       Date:  2022-09-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.